NOTE 1 - ORGANIZATION AND FINANCIAL
CONDITION
Organization and Going Concern
Strategic Environmental & Energy Resources,
Inc. (“SEER,” “we,” or the “Company”), a Nevada corporation, is a provider of next-generation clean-technologies,
waste management innovations and related services. SEER has three wholly-owned subsidiaries in continuing operations, and three
majority-owned subsidiaries; all of which together provide technology solutions and services to companies primarily in the oil
and gas, refining, landfill, food, beverage & agriculture and renewable fuel industries. The three wholly-owned subsidiaries
include: 1) REGS, LLC (d/b/a Resource Environmental Group Services (“REGS”)) provides industrial and proprietary cleaning
services to refineries, oil fields and other private and governmental entities; 2) MV, LLC (d/b/a MV Technologies) (“MV”),
designs and builds biogas conditioning solutions for the production of renewable natural gas and odor control systems primarily
for landfill operations, waste-water treatment facilities, oil and gas fields, refineries, municipalities and food, beverage &
agriculture operations throughout the U.S.; 3) SEER Environmental Materials, LLC,(“SEM”), a materials technology company
focused on development of cost-effective chemical absorbents.
The three majority-owned subsidiaries are;
1) Paragon Waste Solutions, LLC (“PWS”); 2) ReaCH4Biogas (“Reach”) and 3) PelleChar, LLC (“PelleChar”).
PWS is currently owned 54% by SEER (see Note 7), Reach is owned 85% by SEER and PelleChar is owned 51% by SEER.
PWS is developing specific opportunities
to deploy and commercialize patented technologies for a non-thermal plasma-assisted oxidation process that makes possible the clean
and efficient destruction of solid hazardous chemical and biological waste (
i.e
., regulated medical waste, chemicals, pharmaceuticals
and refinery tank waste,
etc
.) without landfilling or traditional incineration and without harmful emissions. Additionally,
PWS’ technology “cleans” and conditions emissions and gaseous waste streams (
i.e
., volatile organic compounds
and other greenhouse gases) generated from diverse sources such as refineries, oil fields, and many others.
Reach (the trade name for BeneFuels, LLC)
focuses specifically on developing renewable biomethane projects that convert raw biogas to pipeline quality gas and/or compressed
natural gas (“CNG”) for fleet vehicle fuel. Reach had no operations for the quarters ended March 31, 2019 and 2018.
PelleChar was formed in September 2018
and recently has secured third-party pellet manufacturing capabilities from one of the nation’s premier pellet manufacturer.
Working closely with Biochar Now, LLC, PelleChar intends to commence sales in 2019 of its proprietary pellets containing the proven
and superior Biochar Now product starting with the landscaping and big agriculture markets. At this time, PelleChar is the
only company able to offer a soil amendment pellet containing the Biochar Now product that is produced using the patented pyrolytic
process. For the quarter ended March 31, 2019 PelleChar had minimal activity related to formation.
Principals of Consolidation
The accompanying consolidated financial
statements include the accounts of SEER, its wholly-owned subsidiaries, REGS, MV and SEM and its majority-owned subsidiaries PWS,
Reach and PelleChar, since their respective acquisition or formation dates. All material intercompany accounts, transactions, and
profits have been eliminated in consolidation. The Company has non-controlling interest in joint ventures, which are reported on
the equity method.
Going Concern
As shown in the accompanying consolidated
financial statements, the Company has experienced recurring losses, and has accumulated a deficit of approximately $25 million
as of March 31, 2019, and $24.4 million as of December 31, 2018. For the three months ended March 31, 2019 and 2018 we had net
losses from continuing operations before adjustment for losses attributable to non-controlling interest of approximately $0.6 million
and $0.7 million, respectively. As of March 31, 2019, and December 31, 2018 our current liabilities exceed our current assets by
approximately $5.4 million and $5.3 million, respectively. The primary reason for the increase in negative working capital from
December 31, 2018 to March 31, 2019 is due to a net increase in short term debt of approximately $.4 million. The Company has limited
common shares available for issue which may limit the ability to raise capital or settle debt through issuance of shares. These
factors raise substantial doubt about the ability of the Company to continue to operate as a going concern for a period of at least
one year after the date of the issuance of our audited financial statements for the period ended December 31, 2018.
NOTE 1 - ORGANIZATION AND FINANCIAL
CONDITION, continued
Realization of a major portion of our assets
as of December 31, 2018, is dependent upon our continued operations. The Company is dependent on generating additional revenue
or obtaining adequate capital to fund operating losses until it becomes profitable. In addition, we have undertaken a number of
specific steps to continue to operate as a going concern. We continue to focus on developing organic growth in our operating companies,
diversifying our service customer base and market concentrations and improving gross and net margins through increased attention
to pricing, aggressive cost management and overhead reductions. Critical to achieving profitability will be our ability to license
and or sell, permit and operate through our joint ventures and licensees our CoronaLux™ waste destruction units. We have
increased our business development efforts to address opportunities identified in expanding domestic markets attributable to increased
federal and state emission control regulations (particularly in the nation’s oil and gas fields) and a growing demand for
energy conservation and renewable energies. In addition, the Company is evaluating various forms of financing that may be available
to it. There can be no assurance that the Company will secure additional financing for working capital, increase revenues and achieve
the desired result of net income and positive cash flow from operations in future years. These financial statements do not give
any effect to any adjustments that would be necessary should the Company be unable to report on a going concern basis.
Basis of presentation Unaudited Interim Financial Information
The accompanying
interim condensed consolidated financial statements are unaudited. In the opinion of management, the accompanying unaudited condensed
consolidated financial statements contain all of the normal recurring adjustments necessary to present fairly the financial position
and results of operations as of and for the periods presented. The interim results are not necessarily indicative of the results
to be expected for the full year or any future period
.
Certain information and footnote disclosures
normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted
in the United States have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission
(“SEC”). The Company believes that the disclosures are adequate to make the interim information presented not misleading.
These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements
and the notes thereto included in the Company’s Report on Form 10-K filed on April 16, 2019 for the years ended December
31, 2018 and 2017.
NOTE 2 - SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
Use of Estimates
The preparation of these consolidated financial
statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to
make a number of estimates and assumptions related to the reported amount of assets and liabilities and the disclosure of contingent
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during
the period. Significant items subject to such estimates and assumptions include the carrying amount of intangible assets; valuation
allowances and reserves for receivables and inventory and deferred income taxes; revenue recognition related to contracts accounted
for under the percentage of completion method; share-based compensation; and loss contingencies, including those related to litigation.
Actual results could differ from those estimates.
Reclassifications
Certain amounts in the prior period financial
statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported
consolidated net loss.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES, continued
Revenue Recognition
In May 2014, the FASB issued guidance on
revenue from contracts with customers that superseded most current revenue recognition guidance, including industry-specific guidance.
The underlying principle of the guidance is to recognize revenue to depict the transfer of goods or services to customers at an
amount to which the company expects to be entitled in exchange for those goods or services. The new guidance requires an evaluation
of revenue arrangements with customers following a five-step approach: (1) identify the contract with a customer; (2) identify
the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance
obligations; and (5) recognize revenue when (or as) the company satisfies each performance obligation. Revenues are recognized
when control of the promised services are transferred to the customers in an amount that reflects the expected consideration in
exchange for those services. A customer obtains control when it has the ability to direct the use of and obtain the benefits from
the services. Other major provisions of the guidance include capitalization of certain contract costs, consideration of the time
value of money in the transaction price and allowing estimates of variable consideration to be recognized before contingencies
are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and
uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the provisions of this guidance
effective January 1, 2018 as required under the guidance. The adoption of this guidance did not have any material impact on the
Company’s consolidated condensed financial statements (see Note 3).
Research and Development
Research and development (“R&D”)
costs are charged to expense as incurred. R&D expenses consist primarily of salaries, project materials, contract labor and
other costs associated with ongoing product development and enhancement efforts. R&D expenses were $0 and $300 for the three
months ended March 31, 2019 and 2018, respectively.
Income Taxes
The Company accounts for income taxes pursuant
to
Accounting Standards Codification
(“ASC”) 740,
Income Taxes,
which utilizes the asset and liability
method of computing deferred income taxes. The objective of this method is to establish deferred tax assets and liabilities for
any temporary differences between the financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted
tax rates expected to be in effect when such amounts are realized or settled.
ASC 740 also provides detailed guidance
for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements.
Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized. During
the three months ended March 31, 2019 and 2018 the Company recognized no adjustments for uncertain tax positions.
The Company recognizes interest and penalties
related to uncertain tax positions in income tax expense. No interest and penalties related to uncertain tax positions were recognized
at March 31, 2019 and December 31, 2018. The Company expects no material changes to unrecognized tax positions within the next
twelve months.
The Company has filed federal and state
tax returns through December 31, 2017. The tax periods for the years ending December 31, 2011 through 2017 are open to examination
by federal and state authorities.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES, continued
Recently issued accounting pronouncements
Changes to accounting principles generally
accepted in the United States of America (U.S. GAAP) are established by the Financial Accounting Standards Board (FASB) in the
form of accounting standards updates (ASU’s) to the FASB’s Accounting Standards Codification. The Company considers
the applicability and impact of all new or revised ASU’s.
Leases
In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842) in order to increase transparency and comparability among organizations by recognizing lease assets and lease
liabilities on the balance sheet for those leases classified as operating leases under prior GAAP. ASU 2016-02 requires that a
lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right
to use the underlying asset for the lease term on the balance sheet. The Company adopted ASU 2016-02 in the first quarter of 2019
utilizing the modified retrospective transition method. The Company has elected the package of practical expedients, which allows
the Company not to reassess (1) whether any expired or existing contracts as of the adoption date are or contain a lease, (2) lease
classification for any expired or existing leases as of the adoption date and (3) initial direct costs for any existing leases
as of the adoption date. The Company did not elect to apply the hindsight practical expedient when determining lease term and assessing
impairment of right-to-use assets. The adoption of ASU 2016-02 on January 1, 2019 resulted in the recognition of right-of-use assets
of approximately $225,300, lease liabilities of $246,100 on its Condensed Consolidated Balance Sheets and a cumulative-effect adjustment
on retained earnings of $20,800 on its Condensed Consolidated Balance Sheets with no material impact to its Condensed Consolidated
Statement of Operations.
NOTE 3 – REVENUE
The Company adopted the provisions of the
guidance in the new revenue standard under ASC 606 effective January 1, 2018 applying the modified retrospective method to all
contracts. Results for reporting periods beginning after January 1, 2018 are presented under the new revenue recognition guidance,
while prior period amounts are not adjusted and continue to be reported in accordance with the historic accounting under previous
revenue recognition guidance. The adoption of this guidance did not have any material impact on the Company’s consolidated
condensed financial statements. There was no impact to net revenue for the year ended December 31, 2018 as a result of applying
the new revenue recognition guidance.
Products Revenue
Product revenue generated from contracts
with customers, for the manufacture of products for the removal and treatment of hazardous vapor and gasses. Total estimated revenue
includes all of the following: (1) the basic contract price, (2) contract options, and (3) change orders.
Once
contract performance is underway, we may experience changes in conditions, client requirements, specifications, designs, materials
and expectations regarding the period of performance. Such changes are “change orders” and may be initiated by us or
by our clients. In many cases, agreement with the client as to the terms of change orders is reached prior to work commencing;
however, sometimes circumstances require that work progress without obtaining client agreement. Revenue related to change orders
is recognized as costs are incurred if it is probable that costs will be recovered by changing the contract price. The Company
does not incur pre-contract costs.
Under the new revenue recognition guidance, we found no change in the manner we recognize
product revenue. Provisions for estimated losses on uncompleted contracts are recorded in the period in which the losses are identified
and included as additional loss. Provisions for estimated losses on contracts are shown separately as liabilities on the balance
sheet, if significant, except in circumstances in which related costs are accumulated on the balance sheet, in which case the provisions
are deducted from the accumulated costs. A provision as a liability is reported as a current liability.
We include in current assets and current
liabilities amounts related to contracts realizable and payable. Costs and estimated earnings in excess of billings on uncompleted
contracts represent the excess of contract costs and profits recognized to date over billings to date and are recognized as a current
asset. Revenue contract liabilities represent the excess of billings to date over the amount of contract costs and profits recognized
to date and are recognized as a current liability.
Products revenue also includes media sales
which are recognized as the product is shipped to the customer for use.
Services Revenue
Our services revenue is primarily comprised
of services related to industrial cleaning and mobile railcar cleaning, which we recognize as services are rendered.
Solid Waste Revenue
The Company’s revenues from waste
destruction licensing agreements are recognized as a single accounting unit over the term of the license. Revenue from joint venture
operations of the Company’s CoronaLux™ units is recognized as the revenue is earned by the joint venture. Revenue from
management services is recognized as services are performed.
Disaggregation of Revenue
|
|
Three months ended March 31, 2019
|
|
|
|
Industrial Cleaning
|
|
|
Environmental Solutions
|
|
|
Solid Waste
|
|
|
Total
|
|
Sources of Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial cleaning services
|
|
$
|
220,200
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
220,200
|
|
Product sales
|
|
|
—
|
|
|
|
889,400
|
|
|
|
—
|
|
|
|
889,400
|
|
Media sales
|
|
|
—
|
|
|
|
200,700
|
|
|
|
—
|
|
|
|
200,700
|
|
Licensing fees
|
|
|
—
|
|
|
|
—
|
|
|
|
25,200
|
|
|
|
25,200
|
|
Operating fees
|
|
|
—
|
|
|
|
—
|
|
|
|
6,900
|
|
|
|
6,900
|
|
Management fees
|
|
|
—
|
|
|
|
—
|
|
|
|
50,000
|
|
|
|
50,000
|
|
Total Revenue
|
|
$
|
220,200
|
|
|
$
|
1,090,100
|
|
|
$
|
82,100
|
|
|
$
|
1,392,400
|
|
|
|
Three months ended March 31, 2018
|
|
|
|
Industrial Cleaning
|
|
|
Environmental Solutions
|
|
|
Solid Waste
|
|
|
Total
|
|
Sources of Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial cleaning services
|
|
$
|
529,700
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
529,700
|
|
Mobile rail car cleaning services
|
|
|
393,500
|
|
|
|
—
|
|
|
|
—
|
|
|
|
393,500
|
|
Product sales
|
|
|
—
|
|
|
|
382,100
|
|
|
|
—
|
|
|
|
382,100
|
|
Media sales
|
|
|
—
|
|
|
|
493,400
|
|
|
|
—
|
|
|
|
493,400
|
|
Licensing fees
|
|
|
—
|
|
|
|
—
|
|
|
|
33,700
|
|
|
|
33,700
|
|
Operating fees
|
|
|
—
|
|
|
|
—
|
|
|
|
13,700
|
|
|
|
13,700
|
|
Management fees
|
|
|
—
|
|
|
|
—
|
|
|
|
50,000
|
|
|
|
50,000
|
|
Total Revenue
|
|
$
|
923,200
|
|
|
$
|
875,500
|
|
|
$
|
97,400
|
|
|
$
|
1,896,100
|
|
Contract Balances
Where a performance
obligation has been satisfied but not yet invoiced at the reporting date, a contract asset is recognized on the balance sheet.
Where a performance obligation has not yet been satisfied but an invoice has been raised at the reporting date, a contract liability
is recognized on the balance sheet.
The opening and closing balances of the
Company’s accounts receivables and contract liabilities (current and non-current) are as follows:
|
|
|
|
|
|
Contract Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
Receivable, net
|
|
|
|
Revenue
Contract Liabilities
|
|
|
|
Deferred Revenue
(current)
|
|
|
|
Deferred Revenue
(non-current)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2019
|
|
$
|
1,297,700
|
|
|
$
|
61,300
|
|
|
$
|
78,900
|
|
|
$
|
55,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2018
|
|
|
1,063,500
|
|
|
|
470,200
|
|
|
|
191,500
|
|
|
|
63,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease)
|
|
$
|
234,200
|
|
|
($
|
408,900
|
)
|
|
($
|
112,600
|
)
|
|
($
|
8,200
|
)
|
The majority of the Company’s revenue
is generally invoiced on a weekly or monthly basis, and the payments are generally received within approximately 30-60 days. Deferred
revenue is recorded when cash payments are received or due in advance of the Company’s performance, including amounts that
are refundable.
Remaining Performance Obligations
As of March 31, 2019, the aggregate
amount of the transaction price allocated to the remaining performance obligations was approximately $1,676,100, of which the Company
expects to recognize revenue of approximately 99% over the next 24 months, including 97% over the next 12 months.
The Company does not disclose the value
of unsatisfied performance obligations for (i) contracts with an original expected term of one year or less and (ii) contracts
for which the Company recognizes revenue at the amounts to which it has the right to invoice for services performed.
NOTE 4 - PROPERTY AND EQUIPMENT
Property and equipment was comprised of
the following:
|
|
March 31,
2019
|
|
|
December 31,
2018
|
|
Field and shop equipment
|
|
$
|
2,272,100
|
|
|
$
|
2,272,100
|
|
Vehicles
|
|
|
690,000
|
|
|
|
690,000
|
|
Waste destruction equipment, placed in service
|
|
|
557,100
|
|
|
|
557,100
|
|
Furniture and office equipment
|
|
|
327,300
|
|
|
|
312,400
|
|
Leasehold improvements
|
|
|
10,000
|
|
|
|
10,000
|
|
Building and improvements
|
|
|
21,200
|
|
|
|
21,200
|
|
Land
|
|
|
162,900
|
|
|
|
162,900
|
|
|
|
|
4,040,600
|
|
|
|
4,025,700
|
|
Less: accumulated depreciation and amortization
|
|
|
(3,294,500
|
)
|
|
|
(3,193,800
|
)
|
Property and equipment, net
|
|
$
|
746,100
|
|
|
$
|
831,900
|
|
Depreciation expense for the three months
ended March 31, 2019 and 2018 was $100,700 and $133,000, respectively. For the three months ended March 31, 2019 depreciation expense
included in cost of goods sold and selling, general and administrative expenses was $83,400 and $17,300 respectively. For the three
months ended March 31, 2018 depreciation expense included in cost of goods sold and selling, general and administrative expenses
was $114,500 and $18,500 respectively.
Accumulated depreciation on leased CoronaLux™
units included in accumulated depreciation and amortization above is $312,200 and $247,000 as of March 31, 2019 and 2018, respectively.
Property and equipment included the following amounts for leases
that have been capitalized at:
|
|
March 31,
|
|
|
December 31
|
|
|
|
2019
|
|
|
2018
|
|
Vehicles, field and shop equipment
|
|
$
|
407,100
|
|
|
$
|
407,100
|
|
Less: accumulated amortization
|
|
|
(312,200
|
)
|
|
|
(298,100
|
)
|
|
|
$
|
94,900
|
|
|
$
|
109,000
|
|
NOTE 5 – INTANGIBLE ASSETS
Intangible assets were comprised of the following:
|
|
March 31, 2019
|
|
|
|
Gross carrying amount
|
|
|
Accumulated amortization
|
|
|
Net carrying value
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
$
|
277,800
|
|
|
|
—
|
|
|
$
|
277,800
|
|
Customer list
|
|
|
42,500
|
|
|
|
(42,500
|
)
|
|
|
—
|
|
Technology
|
|
|
1,021,900
|
|
|
|
(794,500
|
)
|
|
|
227,400
|
|
Trade name
|
|
|
54,900
|
|
|
|
(54,900
|
)
|
|
|
—
|
|
|
|
$
|
1,397,100
|
|
|
$
|
(891,900
|
)
|
|
$
|
505,200
|
|
|
|
December 31, 2018
|
|
|
|
Gross carrying amount
|
|
|
Accumulated amortization
|
|
|
Net carrying value
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
$
|
277,800
|
|
|
|
—
|
|
|
$
|
277,800
|
|
Customer list
|
|
|
42,500
|
|
|
|
(42,500
|
)
|
|
|
—
|
|
Technology
|
|
|
1,021,900
|
|
|
|
(782,900
|
)
|
|
|
239,000
|
|
Trade name
|
|
|
54,900
|
|
|
|
(54,900
|
)
|
|
|
—
|
|
|
|
$
|
1,397,100
|
|
|
$
|
(880,300
|
)
|
|
$
|
516,800
|
|
The estimated useful lives of the intangible
assets range from seven to ten years. Amortization expense was $11,700 and $27,600 for the three months ended March 31, 2019 and
2018, respectively.
NOTE 6 - LEASES
The Company has entered into operating
leases primarily for real estate. These leases have terms which range from 4 year to 6 years, and often include one or more options
to renew. These renewal terms can extend the lease term from 1 year to month-to-month, and are included in the lease term when
it is reasonably certain that the Company will exercise the option. These operating leases are included in “Prepaid expenses
and other current assets” and “Other assets” on the Company’s March 31, 2019 Condensed Consolidated Balance Sheets,
and represent the Company’s right to use the underlying asset for the lease term. The Company’s obligation to make
lease payments are included in “Accrued liabilities” and “Other non-current liabilities” on the Company’s
March 31, 2019 Condensed Consolidated Balance Sheets. Based on the present value of the lease payments for the remaining
lease term of the Company’s existing leases, the Company recognized right-of-use assets of approximately $225,300 and lease liabilities
for operating leases of approximately $246,100 on January 1, 2019. Operating lease right-of-use assets and liabilities commencing
after January 1, 2019 are recognized at commencement date based on the present value of lease payments over the lease term. As
of March 31, 2019, total right-of-use assets and operating lease liabilities were approximately $168,200 and $180,500, respectively.
All operating lease expense is recognized on a straight-line basis over the lease term. In the three months ended March 31, 2019,
the Company recognized approximately $65,600 in operating lease costs for right-of-use assets.
Because the rate implicit in each lease
is not readily determinable, the Company uses its incremental borrowing rate to determine the present value of the lease payments.
The Company has certain contracts for real estate which may contain lease and non-lease components which it has elected to treat
as a single lease component.
Information related to the Company’s right-of-use
assets and related lease liabilities were as follows:
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31, 2019
|
|
|
|
|
|
Cash paid for operating lease liabilities
|
|
$
|
70,900
|
|
Right-of-use assets obtained in exchange for new operating lease obligations (1)
|
|
$
|
168,200
|
|
Weighted-average remaining lease term
|
|
|
12.4 months
|
|
Weighted-average discount rate
|
|
|
10.0
|
%
|
|
(1)
|
Includes $225,300 for operating leases existing on January 1, 2019. No new operating leases commenced
in the first quarter of 2019.
|
Maturities of lease
liabilities as of March 31, 2019 were as follows:
|
|
|
|
Due in 12 month period ended March 31,
|
2020
|
|
|
176,400
|
|
2021
|
|
|
14,400
|
|
|
|
|
190,800
|
|
Less imputed interest
|
|
|
(10,300
|
)
|
Total lease liabilities
|
|
|
180,500
|
|
Current operating lease liabilities
|
|
|
166,600
|
|
Non-current operating lease liabilities
|
|
|
13,900
|
|
Total lease liabilities
|
|
|
180,500
|
|
The Company has an additional operating
lease for real estate of $420,400 which has not commenced as of March 31, 2019, and as such, has not been recognized on the Company’s
Condensed Consolidated Balance Sheet. This operating lease is expected to commence in the second quarter of 2019 with a lease terms
of 7 years and 4 months.
NOTE 7 - ACCRUED LIABILITIES
Accrued liabilities were comprised of the
following:
|
|
March 31,
2019
|
|
|
December 31,
2018
|
|
|
|
|
|
|
|
|
Accrued compensation and related taxes
|
|
$
|
533,200
|
|
|
$
|
565,800
|
|
Accrued interest
|
|
|
351,100
|
|
|
|
362,000
|
|
Accrued settlement/litigation claims
|
|
|
150,000
|
|
|
|
150,000
|
|
Warranty and defect claims
|
|
|
40,600
|
|
|
|
55,000
|
|
Lease liabilities
|
|
|
180,500
|
|
|
|
—
|
|
Other
|
|
|
155,200
|
|
|
|
293,300
|
|
Total Accrued Liabilities
|
|
$
|
1,410,600
|
|
|
$
|
1,426,100
|
|
NOTE 8 - UNCOMPLETED CONTRACTS
Costs, estimated earnings and billings
on uncompleted contracts are as follows:
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Revenue Recognized
|
|
$
|
179,300
|
|
|
$
|
499,600
|
|
Less: Billings to date
|
|
|
(118,000
|
)
|
|
|
(185,300
|
)
|
Costs and estimated earnings in excess of billings on uncompleted contracts
|
|
$
|
61,300
|
|
|
$
|
314,300
|
|
|
|
|
|
|
|
|
|
|
Billings to date
|
|
$
|
1,143,300
|
|
|
$
|
1,642,600
|
|
Revenue recognized
|
|
|
(495,800
|
)
|
|
|
(1,172,400
|
)
|
Revenue contract liabilities
|
|
$
|
647,500
|
|
|
$
|
470,200
|
|
NOTE 9 – INVESTMENT IN PARAGON WASTE SOLUTIONS
LLC
Since its inception through March 31, 2019,
we have provided approximately $6.6 million in funding to PWS for working capital and the further development and construction
of various prototypes and commercial waste destruction units. No members of PWS have made capital contributions or other funding
to PWS other than SEER. The intent of the operating agreement is that we will provide the funding as an advance against future
earnings distributions made by PWS.
Payments received for non-refundable licensing
and placement fees have been recorded as deferred revenue in the accompanying consolidated balance sheets at March 31, 2019 and
December 31, 2018 and are recognized as revenue ratably over the term of the contract.
NOTE 10 - PAYROLL TAXES PAYABLE
In 2009 and 2010, REGS, a subsidiary of
the Company, became delinquent for unpaid federal employer and employee payroll taxes, accrued interest and penalties were incurred
related to these unpaid payroll taxes.
As of March 31, 2019, and December 31,
2018, the outstanding balance due to the IRS was $1,030,800, and $1,022,500, respectively.
Other than this outstanding payroll tax
matter arising in 2009 and 2010, all state and federal taxes have been paid by REGS in a timely manner.
NOTE 11 – DEBT
Debt as of March 31, 2019 and December
31, 2018, was comprised of the following:
|
|
3/31/2019
|
|
|
12/31/2018
|
|
|
|
|
|
|
|
|
SHORT TERM NOTES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Secured short term note payable dated September 13, 2017 with principal and interest due 60 days from issuance. The note requires a one-time fee in the amount of $15,000 to compensate for the first two weeks of the term and each week thereafter (weeks 3-8) a fee of $1,500 shall be due and owing accruing on the first day of the week. The total one time fee paid was $24,000. A fee of 100,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 200,000 shares of restricted common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued has been reached. For the year ended December 31, 2018, the Company recorded 2,300,000 shares of its common stock as issuable under the terms of this agreement, valued at $667,800 and recorded as interest expense. For the quarter ended March 31, 2019, the Company recorded an additional 200,000 shares of its common stock under the terms of this agreement, valued at $19,000 and recorded as interest expense. This note was converted to minority investment in new subsidiary in February 2019.
|
|
|
—
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
Secured short term note payable dated October 13, 2017 with principal and interest due 60 days from issuance. The note requires a one-time fee in the amount of $4,000 to compensate for the first two weeks of the term and each week thereafter (weeks 3-8) a fee of $400 shall be due and owing accruing on the first day of the week. The total one time fee paid was $6,400. A fee of 40,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 80,000 shares of restricted common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued has been reached for the years ended December 31, 2018 and 2017, however, the debt holder agreed to a reduction and a fixed amount of penalty shares in 2018, and the Company recorded 310,000 shares and 40,000 shares of its common stock, respectively, as issuable under the terms of this agreement. The shares were valued at $137,500 and $30,000 for the years ended December 31, 2018 and 2017, respectively, and were recorded as interest expense in the applicable period. No additional shares will be issued by the Company. The reduction of penalty shares was accounted for as debt extinguishment and a gain was recorded in the period.
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
Secured short term note payable dated November 6, 2017 with principal and interest due 60 days from issuance. The note requires a one-time fee in the amount of $5,000 to compensate for the first two weeks of the term and each week thereafter (weeks 3-8) a fee of $400 shall be due and owing accruing on the first day of the week. The total one time fee paid was $7,400. A fee of 50,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 100,000 shares of restricted common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued had not been reached as of December 31, 2017 but was reached as of December 31, 2018, however, the debt holder agreed to a reduced and fixed amount of penalty shares during 2018. During the year ended December 31, 2018, the Company recorded 350,000 shares of its common stock as issuable under the terms of this agreement. The shares were valued at $153,900 recorded as interest expense. No additional shares will be issued by the Company. The reduction of penalty shares was accounted for as debt extinguishment and a gain was recorded in the period.
|
|
|
125,000
|
|
|
|
125,000
|
|
|
|
3/31/2019
|
|
|
12/31/2018
|
|
|
|
|
|
|
|
|
Note payable dated November 20, 2017, interest at 30% per annum, principal and accrued interest due on or before February 28, 2018. Unpaid interest at December 31, 2018 is approximately $37,500. The note is unsecured. During 2018, a verbal agreement was made to allow month-to-month extension of the due date as long as interest payments were made monthly. The Company made interest payments totaling $64,100 of which $37,726 of interest and principal reduction of $1,900 was paid by the issuance of 140,000 shares of common stock during 2018 and the note holder has continued to extend the due date.
|
|
|
298,100
|
|
|
|
298,100
|
|
|
|
|
|
|
|
|
|
|
Secured short term note payable dated January 26, 2018 with principal and interest due 60 days from issuance. The note required a one-time fee in the amount of $12,500 to compensate for the first two weeks of the term and each week thereafter (weeks 3-8) a fee of $1,250 accrued on the first day of the week. The total one time fee paid was $17,500. A fee of 100,000 shares of restricted common stock accrued as a penalty for each month or prorated for any two-week portion of any month the note was outstanding past the original maturity date for months 3 through 6, and a fee of 200,000 shares of restricted common stock accrued to the lender for each month or prorated for each two-week portion of any month the note was outstanding past the original maturity date beginning in month 7 until paid in full. The note was secured by the future sale of CoronaLux™ units and a personal guarantee of an officer of the Company. This note was paid in full during September 2018 and 700,000 of penalty shares were issued, valued at $200,000 recorded as interest.
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Note payable dated February 27, 2018 due on or before May 31, 2018 requiring a one-time fee in the amount of $25,000 to be paid as interest along with the principal on the due date. Because the note and interest were not paid on or before June 1, 2018, a fee of $5,000 accrued on the first day of each month commencing June 1, 2018. The note was secured by all of the proceeds from the sale of SEM’s BioActive Media paid to or received by SEM or MV. This note principal was paid in full in September 2018. Unpaid interest at December 31, 2018 is approximately $40,000.
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Secured short term note payable dated February 1, 2019 with principal and interest due 90 days from issuance. The note requires a one-time fee in the amount of $15,000 to compensate for the first two weeks of the term and each week thereafter (weeks 3-12) a fee of $1,500 shall be due and owing accruing on the first day of the week. The total one time fee paid was $30,000. A fee of 50,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion of any month the note is outstanding past the original maturity date for months 4 through 6, and a fee of 100,000 shares of restricted common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of any and all PelleChar products and a personal guarantee of an officer of the Company. The penalty period for shares to be issued has not been reached.
|
|
|
500,000
|
|
|
|
—
|
|
|
|
3/31/2019
|
|
|
12/31/2018
|
|
|
|
|
|
|
|
|
Note payable insurance premium financing, interest at 2.12% per annum, payable in 10 installments of $33,000, due November 1, 2019.
|
|
|
231,100
|
|
|
|
—
|
|
Total short term notes
|
|
|
1,254,200
|
|
|
|
823,100
|
|
|
|
|
|
|
|
|
|
|
CONVERTIBLE NOTES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes payable, interest at 8% per annum, unpaid principal and interest maturing 3 years from note date between August 2018 and October 2019, convertible into common stock at the option of the lenders at a rate of $0.70 per share; one convertible note for $250,000 has a personal guarantee of an officer of the Company. The notes that matured in August 2018, were subsequently extended by one year to August 2019, all other terms remained the same. The note that matured November 2018 was subsequently extended to May 2019 and the interest rate increased to 13% per annum.
|
|
|
1,605,000
|
|
|
|
1,605,000
|
|
|
|
|
|
|
|
|
|
|
Debt discount
|
|
|
(900
|
)
|
|
|
(1,400
|
)
|
Total convertible notes
|
|
|
1,604,100
|
|
|
|
1,603,600
|
|
Less: current portion
|
|
|
(1,604,100
|
)
|
|
|
(1,603,600
|
)
|
Long term convertible notes, including debt discount
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
LONG TERM NOTES AND CAPITAL LEASE OBLIGATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note payable dated July 13, 2018, interest at 20% per annum, payable July 13, 2021. No monthly payments are due for the first six months, commencing in month seven, principal and accrued interest will be amortized and payable over the remaining 30 months. The note is secured by all assets of SEM and personally guaranteed by an officer of the Company. A fee of 200,000 shares of restricted common stock was issuable at the time of funding. During the year ended December 31, 2018, the Company recorded 200,000 shares of its common stock as issuable under the terms of this agreement. The shares were valued at $44,000 recorded as debt discount. Unpaid interest at December 31, 2018 was approximately $46,900.
|
|
|
500,000
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
Debt discount
|
|
|
(34,200
|
)
|
|
|
(37,900
|
)
|
|
|
|
|
|
|
|
|
|
Note payable dated October 13, 2015, interest at 8% per annum, payable in 60 monthly installments of principal and interest $4,562, due October 1, 2020. Secured by real estate and other assets of SEM and guaranteed by SEER and MV.
|
|
|
81,100
|
|
|
|
92,000
|
|
|
|
|
|
|
|
|
|
|
Capital lease obligations, secured by certain assets, maturing through Nov 2020
|
|
|
49,500
|
|
|
|
57,900
|
|
Total long term notes and capital lease obligations
|
|
|
596,400
|
|
|
|
612,000
|
|
Less: current portion
|
|
|
(228,600
|
)
|
|
|
(71,200
|
)
|
Long term notes and capital lease obligations, long-term, including debt discount
|
|
$
|
367,800
|
|
|
$
|
540,800
|
|
NOTE 12 – RELATED PARTY TRANSACTIONS
Notes payable, related parties
Related parties accrued interest due to
certain related parties as of March 31, 2019 and December 31, 2018 are as follows:
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Accrued interest
|
|
$
|
11,800
|
|
|
$
|
11,800
|
|
|
|
$
|
11,800
|
|
|
$
|
11,800
|
|
We believe the stated interest rates on
the related party notes payable represent reasonable market rates based on the note payable arrangements we have executed with
third parties.
In March 2012, the Company entered into
an Irrevocable License & Royalty Agreement with PWS that grants PWS an irrevocable world-wide license to the IP in exchange
for a 5% royalty on all revenues from PWS and its affiliates. The term commenced as of the date of the Agreement and shall continue
for a period not to exceed the life of the patent or patents filed by the Company. PWS may sub license the IP and any revenue derived
from sub licensing shall be included in the calculation of Gross Revenue for purposes of determining royalty payments due the Company.
Royalty payments are due 30 days after the end of each calendar quarter. PWS generated licensing and unit sales revenues of approximately
$25,200 for the three months ended March 31, 2019 and $134,800 for the years ended December 31, 2018, as such, royalties of $121,600
and $120,300 were due at March 31, 2019 and December 31, 2018, respectively.
In October 2014, PWS and Medical Waste
Services, LLC (“MWS”) formed a contractual joint venture to exploit the PWS medical waste destruction technology. In
2015, MWS licensed and installed a CoronaLux™ unit at an MWS facility, and subsequently received a limited permit to operate.
In November 2017 a full permit was issued and the unit is now fully operating. Operations to date have included the destruction
of medical waste. For the three months ended March 31, 2019 and the year ended December 31, 2018, PWS has recorded $6,900 and $34,400
in income which represents their 50% interest in the net income of the joint venture, respectively. PWS did not incur any costs
incurred on behalf of the joint venture for the three months ended March 31, 2019 nor the year ended December 31, 2018.
NOTE
13 – EQUITY TRANSACTIONS
2019
During the three months ended March 31,
2019, the Company issued 200,000 shares of $.001 par value common stock to short-term note holders as required under their respective
agreements. (See Note 11)
2018
During the three months ended March 31,
2018, the Company recorded 570,000 shares of $.001 par value common stock as issuable to short-term note holders as required under
their respective agreements. (See Note 11)
During the three months ended March 31,
2018, the Company sold 250,000 shares of $.001 par value common stock at $.48 per share in a private placement, receiving proceeds
of $120,000.
Non-controlling Interest
The non-controlling interest presented
in our condensed consolidated financial statements reflects a 46% non-controlling equity interest in PWS and 49% non-controlling
equity interest in PelleChar. Net losses attributable to non-controlling interest, as reported on our condensed consolidated statements
of operations, represents the net loss of each entity attributable to the non-controlling equity interest. The non-controlling
interest is reflected within stockholders’ equity on the condensed consolidated balance sheet.
NOTE 14 – CUSTOMER
CONCENTRATIONS
The Company had sales from operations to
three customers for the three months ended March 31, 2019 and two customers for the three months ended March 31, 2018 that represented
approximately 74% and 31% of our total sales, respectively. The concentration of the Company’s business with a relatively
small number of customers may expose us to a material adverse effect if one or more of these large customers were to experience
financial difficulty or were to cease being customer for non-financial related issues.
NOTE 15 – NET LOSS PER SHARE
Basic net loss per share is computed by
dividing net loss attributable to common shareholders by the weighted average number of common shares outstanding. Diluted net
loss per share is computed by dividing net loss attributable to common shareholders by the weighted average number of common shares
outstanding plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common
shares. Potentially dilutive securities are excluded from the calculation when their effect would be anti-dilutive. For all years
presented in the consolidated financial statements, all potentially dilutive securities have been excluded from the diluted share
calculations as they were anti-dilutive as a result of the net losses incurred for the respective years. Accordingly, basic shares
equal diluted shares for all years presented.
Potentially dilutive securities were comprised of the following:
|
|
Three Months Ended March 31,
|
|
|
|
2019
|
|
2018
|
|
Warrants
|
|
|
2,268,900
|
|
|
|
7,658,400
|
|
Options
|
|
|
125,000
|
|
|
|
1,572,500
|
|
Convertible notes payable, including accrued interest
|
|
|
2,516,100
|
|
|
|
2,417,300
|
|
|
|
|
4,910,000
|
|
|
|
11,648,200
|
|
NOTE 16 - ENVIRONMENTAL MATTERS AND
REGULATION
Significant federal environmental laws
affecting us are the Resource Conservation and Recovery Act (“RCRA”), the Comprehensive Environmental Response, Compensation
and Liability Act (“CERCLA”), also known as the “Superfund Act”, the Clean Air Act, the Clean Water Act and
the Toxic Substances Control Act (“TSCA”).
Pursuant to the EPA’s authorization
of the RCRA equivalent programs, a number of states have regulatory programs governing the operations and permitting of hazardous
waste facilities. Our facilities are regulated pursuant to state statutes, including those addressing clean water and clean air.
Our facilities are also subject to local siting, zoning and land use restrictions. We believe we are in substantial compliance
with all federal, state and local laws regulating our business.
NOTE 17 - SEGMENT INFORMATION AND MAJOR CUSTOMERS
The Company currently has identified
three segments as follows:
REGS
|
Industrial Cleaning
|
MV and SEM
|
Environmental Solutions
|
PWS
|
Solid Waste
|
Reach and PelleChar had minimal
operations through March 31, 2019.
The composition of our reportable segments
is consistent with that used by our Chief Operating Decision Maker (“CODM”) to evaluate performance and allocate resources.
All of our operations are located in the U.S. We have not allocated corporate selling, general and administrative expenses, and
stock-based compensation to the segments. All intercompany transactions have been eliminated.
Segment information for the three months ended March 31, 2019
and 2018 is as follows:
2019
|
|
Industrial
|
|
|
Environmental
|
|
|
Solid
|
|
|
|
|
|
|
|
|
|
Cleaning
|
|
|
Solutions
|
|
|
Waste
|
|
|
Corporate
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
220,200
|
|
|
$
|
1,090,100
|
|
|
$
|
82,100
|
|
|
$
|
—
|
|
|
$
|
1,392,400
|
|
Depreciation and amortization (1)
|
|
|
50,900
|
|
|
|
13,400
|
|
|
|
27,800
|
|
|
|
20,300
|
|
|
|
112,400
|
|
Interest expense
|
|
|
10,700
|
|
|
|
1,900
|
|
|
|
1,600
|
|
|
|
135,600
|
|
|
|
149,800
|
|
Stock-based compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
500
|
|
|
|
500
|
|
Net income (loss)
|
|
|
(336,700
|
)
|
|
|
243,500
|
|
|
|
(60,200
|
)
|
|
|
(425,500
|
)
|
|
|
(578,900
|
)
|
Capital expenditures (cash and noncash)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
15,000
|
|
|
|
15,000
|
|
Total assets
|
|
$
|
586,200
|
|
|
|
1,946,200
|
|
|
$
|
380,400
|
|
|
$
|
1,213,500
|
|
|
$
|
4,126,300
|
|
2018
|
|
Industrial
|
|
|
Environmental
|
|
|
Solid
|
|
|
|
|
|
|
|
|
|
Cleaning
|
|
|
Solutions
|
|
|
Waste
|
|
|
Corporate
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
923,200
|
|
|
$
|
875,500
|
|
|
$
|
97,400
|
|
|
$
|
—
|
|
|
$
|
1,896,100
|
|
Depreciation and amortization (1)
|
|
|
76,200
|
|
|
|
44,400
|
|
|
|
19,300
|
|
|
|
20,700
|
|
|
|
160,600
|
|
Interest expense
|
|
|
15,200
|
|
|
|
2,600
|
|
|
|
—
|
|
|
|
348,000
|
|
|
|
365,800
|
|
Stock-based compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
35,500
|
|
|
|
35,500
|
|
Net income (loss)
|
|
|
(77,500
|
)
|
|
|
120,600
|
|
|
|
(36,100
|
)
|
|
|
(754,300
|
)
|
|
|
(747,300
|
)
|
Capital expenditures (cash and noncash)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Total assets
|
|
$
|
982,100
|
|
|
|
1,008,400
|
|
|
$
|
526,400
|
|
|
$
|
1,546,400
|
|
|
$
|
4,063,300
|
|
|
(1)
|
Includes depreciation of property, equipment and leasehold improvement and amortization of intangibles
|
NOTE 18 – LITIGATION
In January 2016, an employee of SEM was
involved in a vehicle accident while on Company business. Various actions were filed by the claimants in both state and federal
courts. In August 2016, an involuntary proceeding was commenced by one of the claimants against SEM under Chapter 7 of the Bankruptcy
code. In September 2016, the case was converted to a Chapter 11 under the Bankruptcy code. During the pendency of all actions,
SEM continued to manage its affairs and operate normally. In the fourth quarter of 2016, the parties reached a settlement concerning
the distribution of insurance proceeds and all issues of liability. On March 27, 2017 the Bankruptcy Courts confirmed the dismissal
of the SEM Chapter 11 case. As part of the bankruptcy proceedings, the Company reached a settlement with claimants and recorded
an accrued litigation expense of $212,500 at December 31, 2016. It was agreed among the parties that all pending state and/or federal
claims will be dismissed with prejudice. The accrued litigation outstanding at March 31, 2019 and December 31, 2018 was $133,333
and $133,333, respectively.
In October 2018, a complaint was filed
by a contractor company of a mutual customer of MV, a subsidiary of the Company. The complaint claimed that in 2016 MV delivered
defective and poorly manufactured treatment vessels to the project and that due to such delivery, the contractor company sustained
$251,160 in damages in the effort to repair the error. At the same time, the mutual customer had an outstanding balance due MV
of $224,000 and MV had an outstanding balance due the vessel manufacturer of $82,600. In the first quarter of 2019, the parties
reached a settlement whereby MV paid the contractor company a total of $160,000, the joint customer paid the outstanding invoice
amounts of $224,000 and the vessel manufacturer waived the $82,600 due from MV for the faultily manufactured vessel. The case was
dismissed with prejudiced and the matter is closed.
NOTE 19 - SUBSEQUENT EVENTS
On April 15, 2019, the Company borrowed $10,000 from an officer
of the Company. The unsecured promissory note is due May 10, 2019 and carries interest of 8% with a minimum of $250 of interest
payable. This note was paid in full plus $250 of interest on May 7, 2019.
On May 1, 2019, the Company entered into an Accord and Satisfaction
Agreement to facilitate an early and final payment of all remaining earnout and bonus payments from the sale of assets completed
in 2017. The final payment received by the Company in May 2019 totaled $515,000.